{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-098792","form_type":"8-K","ticker":"AIDX","cik":"0001139685","company_name":"20/20 Biolabs, Inc.","filed_at":"2026-09-10T20:10:32+00:00","discovered_at":"2026-09-10T20:12:29.579042+00:00","generated_at":"2026-09-10T20:12:38.861142+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"20/20 Biolabs gets Nasdaq equity non-compliance notice; delisting risk","bullets":["On Sept 3, 2026, Nasdaq notified 20/20 Biolabs of non-compliance with $2.5M stockholders' equity rule; reported equity $1.62M.","Company has 45 days to submit compliance plan; if accepted, extension up to 180 days possible.","Also previously notified July 17, 2026 of bid price non-compliance; must regain $1.00 bid by Jan 13, 2027.","Failure to cure equity by Jan 13, 2027 would also disqualify additional bid-price cure period.","Company intends to monitor and consider options to regain compliance."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-098792","json":"https://secwatch.observer/filing/0001213900-26-098792.json","markdown":"https://secwatch.observer/filing/0001213900-26-098792.md","text":"https://secwatch.observer/filing/0001213900-26-098792.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1139685/000121390026098792/0001213900-26-098792-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1139685/000121390026098792/ea0305119-8k_2020bio.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-10T20:12:38.861142+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}